BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.1900
-0.0206 (-9.78%)
At close: Feb 9, 2026, 4:00 PM EST
0.1600
-0.0300 (-15.79%)
Pre-market: Feb 10, 2026, 4:31 AM EST
BioAtla Market Cap
BioAtla has a market cap or net worth of $12.17 million as of February 10, 2026. Its market cap has decreased by -58.03% in one year.
Market Cap
12.17M
Enterprise Value
9.75M
1-Year Change
-58.03%
Ranking
Category
Stock Price
$0.19
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $12.17M, a decrease of -97.89%. That is a compound annual growth rate of -52.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 12.17M | -63.69% |
| Dec 31, 2025 | 33.51M | -2.30% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -69.81% |
| Dec 30, 2022 | 390.66M | -45.97% |
| Dec 31, 2021 | 723.09M | -36.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GT Biopharma | 14.36M |
| OSR Holdings | 14.12M |
| CytoMed Therapeutics | 13.50M |
| Cocrystal Pharma | 13.37M |
| Allarity Therapeutics | 13.36M |
| Cadrenal Therapeutics | 13.33M |
| Curis | 13.32M |
| Moleculin Biotech | 13.27M |